Log In
Print
BCIQ
Print
Print this Print this
 

Cosopt, dorzolamide/timolol maleate

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionTopical carbonic anhydrase inhibitor and adrenergic receptor beta (ADRB) blocker
Molecular Target Carbonic anhydrase II (CAII) ; Adrenergic receptor beta (ADRB)
Mechanism of ActionAdrenergic receptor beta (ADRB) agonist; Carbonic anhydrase inhibitor
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationOcular hypertension
Indication DetailsTreat intraocular pressure
Regulatory Designation

Partner

Akorn Inc.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$805.6M

$705.6M

$100.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today